A recent legal document reveals that the Director of Contracts for the Defense Advanced Research Projects Agency (DARPA) is working to keep funding for high-risk virus research, despite cuts imposed by President Donald Trump affecting Harvard University.
Unnamed officials are reportedly challenging the Pentagon, arguing that grants to Harvard could serve as an essential proof of concept for DARPA’s complete program. This includes initiatives aimed at safely transporting viruses and other pathogens from remote areas to research labs. Legal papers have surfaced in connection to this matter.
Harvard’s legal team is emphasizing accounts from DARPA officials who have expressed dissatisfaction with the trial motions related to the case. According to reports, there are concerns about the Trump administration’s approach, which some claim lacks critical thought and has resulted in negative consequences.
On the other hand, the filing does not capture the apprehensions voiced by various science advocates regarding the practice of moving viruses from isolated regions to laboratories. Notably, concerns have been raised about potential biological threats stemming from such research, especially given that similar studies might have contributed to the emergence of the Covid-19 pandemic.
Attempts to get a comment from DARPA went unanswered.
Harvard initiated a lawsuit against Trump after negotiations over related government issues broke down on April 21. The university’s Task Force reported that certain instructors have been accused of normalizing experiences of anti-Semitism and anti-Israel bias that some students have faced.
DARPA’s objectives, as outlined in a proposal from July 2023, include preserving pathogens while detecting new threats. Some scientists refer to this field as “virus hunting,” involving the collection and cataloging of viruses from various wildlife sources. Understanding which wild viruses could potentially trigger a pandemic could lead to increased infectivity and lethality in controlled environments.
The proposed program emphasizes the need for reliable methods to store microorganisms, aiming to enhance the Pentagon’s ability to investigate emerging threats.
Officials assert that Harvard plays a critical role in the Amphora program, stating that the termination of funding would severely impact national security.
Nonetheless, some scientists, including National Health Director Jay Bhattacharya, have warned that these types of projects carry risks of igniting new pandemics. There are fears that experiments conducted in labs could exacerbate human disease transmission.
Bhattacharya commented on the method used in these research programs, highlighting the dangerous nature of collecting pathogens in various wild areas and the interactions humans have with these environments. He noted that such research could be the underlying cause of community pandemics.
In another development, plans for a U.S. International Development Virus Hunting Program, dubbed Deep VZN, have been quietly shelved.
A previous DARPA initiative from 2018 aimed to include the Wuhan Virus Institute, which was in conjunction with American partners. Proposals outlined a research plan to analyze viruses with specific genomic features associated with the Covid-19 virus. However, concerns about safety led DARPA officials to reject such proposals.
